{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 6,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 1
      },
      "2": {
        "core": 1,
        "branch": 1
      },
      "3": {
        "core": 1,
        "branch": 1
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A11 ∨ A12)",
        "prover9_expression": "(positive(patient_response) | minimal(side_effects))",
        "natural": "Patient response is positive or side effects are minimal."
      },
      {
        "id": "Rule2",
        "formal": "(A12 → G)",
        "prover9_expression": "(minimal(side_effects) -> safe(medication))",
        "natural": "Whenever side effects are minimal, the medication is safe."
      },
      {
        "id": "Rule3",
        "formal": "(A15 → A14)",
        "prover9_expression": "(compliant(regulatory_standards) -> approved(manufacturing_process))",
        "natural": "If regulatory standards are compliant, then the manufacturing process is approved."
      },
      {
        "id": "Rule4",
        "formal": "(A15 ∨ A16)",
        "prover9_expression": "(compliant(regulatory_standards) | validated(equipment))",
        "natural": "Regulatory standards are compliant or equipment is validated."
      },
      {
        "id": "Rule5",
        "formal": "(A16 → (¬(A11 → A10) → ¬A13))",
        "prover9_expression": "(validated(equipment) -> (-(positive(patient_response) -> successful(clinical_trial)) -> -extended(trial_period)))",
        "natural": "Assuming equipment is validated, then if it is not the case that positive patient response leads to a successful clinical trial, the trial period is not extended."
      },
      {
        "id": "Rule6",
        "formal": "(A17 → A1)",
        "prover9_expression": "(initiated(phase_three) -> approved(clinical_trial))",
        "natural": "In the event that phase three is initiated, the clinical trial is approved."
      },
      {
        "id": "Rule7",
        "formal": "(A20 → ¬A6)",
        "prover9_expression": "(detected(contamination) -> -contaminated(batch))",
        "natural": "Given that contamination is detected, the batch is not contaminated."
      },
      {
        "id": "Rule8",
        "formal": "(A21 → ¬A6)",
        "prover9_expression": "(identified(impurity) -> -contaminated(batch))",
        "natural": "Should an impurity be identified, the batch is not contaminated."
      },
      {
        "id": "Rule9",
        "formal": "(A24 → A23)",
        "prover9_expression": "(initiated(recall_procedure) -> failed(quality_assurance))",
        "natural": "If recall procedure is initiated, then quality assurance is failed."
      },
      {
        "id": "Rule10",
        "formal": "(A25 → A26)",
        "prover9_expression": "(profitable(product_line) -> increased(market_share))",
        "natural": "Provided that the product line is profitable, market share is increased."
      },
      {
        "id": "Rule11",
        "formal": "(A25 ∨ (A11 → A10))",
        "prover9_expression": "(profitable(product_line) | (positive(patient_response) -> successful(clinical_trial)))",
        "natural": "The product line is profitable or positive patient response implies a successful clinical trial."
      },
      {
        "id": "Rule12",
        "formal": "(A3 → ¬A2)",
        "prover9_expression": "(resumed(production) -> -halted(production))",
        "natural": "In the case that production is resumed, production is not halted."
      },
      {
        "id": "Rule13",
        "formal": "(A4 → G)",
        "prover9_expression": "(effective(drug_formula) -> safe(medication))",
        "natural": "If the drug formula is effective, then the medication is safe."
      },
      {
        "id": "Rule14",
        "formal": "(A4 ∨ A5)",
        "prover9_expression": "(effective(drug_formula) | stable(chemical_compound))",
        "natural": "Either the drug formula is effective or the chemical compound is stable."
      },
      {
        "id": "Rule15",
        "formal": "(A6 ∨ (A5 → G))",
        "prover9_expression": "(contaminated(batch) | (stable(chemical_compound) -> safe(medication)))",
        "natural": "The batch is contaminated or if the chemical compound is stable, then the medication is safe."
      },
      {
        "id": "Rule16",
        "formal": "(A7 → ¬A6)",
        "prover9_expression": "(passed(quality_test) -> -contaminated(batch))",
        "natural": "Should the quality test be passed, the batch is not contaminated."
      },
      {
        "id": "Rule17",
        "formal": "(A7 ∨ A8)",
        "prover9_expression": "(passed(quality_test) | approved(sterilization))",
        "natural": "Either the quality test is passed or sterilization is approved."
      },
      {
        "id": "Rule18",
        "formal": "(A8 → A9)",
        "prover9_expression": "(approved(sterilization) -> completed(packaging))",
        "natural": "Provided that sterilization is approved, packaging is completed."
      },
      {
        "id": "Rule19",
        "formal": "(A9 → ¬A6)",
        "prover9_expression": "(completed(packaging) -> -contaminated(batch))",
        "natural": "In the event that packaging is completed, the batch is not contaminated."
      },
      {
        "id": "Rule20",
        "formal": "(¬(A11 → A10) → A13)",
        "prover9_expression": "(-(positive(patient_response) -> successful(clinical_trial)) -> extended(trial_period))",
        "natural": "If it is not the case that positive patient response implies a successful clinical trial, then the trial period is extended."
      },
      {
        "id": "Rule21",
        "formal": "(¬(A22 → (A20 ∨ A21)) → A24)",
        "prover9_expression": "(-(conducted(microbial_testing) -> (detected(contamination) | identified(impurity))) -> initiated(recall_procedure))",
        "natural": "If it is not the case that conducted microbial testing leads to either detected contamination or identified impurity, then recall procedure is initiated."
      },
      {
        "id": "Rule22",
        "formal": "(¬(¬(¬G → A17) → A18) → A19)",
        "prover9_expression": "(-(-(-safe(medication) -> initiated(phase_three)) -> completed(phase_three)) -> submitted(fda_application))",
        "natural": "Provided that it is not the case that not not safe medication implies initiated phase three leads to completed phase three, then the FDA application is submitted."
      },
      {
        "id": "Rule23",
        "formal": "(¬(¬(¬G → A17) → A18) → ¬A19)",
        "prover9_expression": "(-(-(-safe(medication) -> initiated(phase_three)) -> completed(phase_three)) -> -submitted(fda_application))",
        "natural": "In the case that it is not the case that not not safe medication implies initiated phase three leads to completed phase three, then the FDA application is not submitted."
      },
      {
        "id": "Rule24",
        "formal": "(¬(¬G → A1) → A2)",
        "prover9_expression": "(-(-safe(medication) -> approved(clinical_trial)) -> halted(production))",
        "natural": "If it is not the case that not safe medication implies approved clinical trial, then production is halted."
      },
      {
        "id": "Rule25",
        "formal": "(¬(¬G → A1) → A3)",
        "prover9_expression": "(-(-safe(medication) -> approved(clinical_trial)) -> resumed(production))",
        "natural": "Assuming it is not the case that not safe medication implies approved clinical trial, production is resumed."
      },
      {
        "id": "Rule26",
        "formal": "(¬G → ¬A1)",
        "prover9_expression": "(-safe(medication) -> -approved(clinical_trial))",
        "natural": "Whenever the medication is not safe, the clinical trial is not approved."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A22",
        "prover9_expression": "conducted(microbial_testing)",
        "natural": "Microbial testing is conducted."
      },
      {
        "id": "Fact2",
        "formal": "¬A10",
        "prover9_expression": "-successful(clinical_trial)",
        "natural": "It is not the case that the clinical trial is successful."
      },
      {
        "id": "Fact3",
        "formal": "¬A14",
        "prover9_expression": "-approved(manufacturing_process)",
        "natural": "The manufacturing process is not approved."
      },
      {
        "id": "Fact4",
        "formal": "¬A18",
        "prover9_expression": "-completed(phase_three)",
        "natural": "Phase three is not completed."
      },
      {
        "id": "Fact5",
        "formal": "¬A23",
        "prover9_expression": "-failed(quality_assurance)",
        "natural": "Quality assurance is not failed."
      },
      {
        "id": "Fact6",
        "formal": "¬A26",
        "prover9_expression": "-increased(market_share)",
        "natural": "Market share is not increased."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "safe(medication)",
    "natural": "The medication is safe."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-G -> A1) -> A3)",
            "(A3 -> -A2)"
          ],
          "conclusion": "(-(-G -> A1) -> -A2)",
          "natural": "Provided that it is not the case that not safe medication implies approved clinical trial, production is not halted."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-G -> A1) -> A2)",
            "(-(-G -> A1) -> -A2)"
          ],
          "conclusion": "(-G -> A1)",
          "natural": "If the medication is not safe, then the clinical trial is approved."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A1)",
            "(-G -> -A1)"
          ],
          "conclusion": "G",
          "natural": "The medication is safe."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A8 -> A9)",
            "(A9 -> -A6)"
          ],
          "conclusion": "(A8 -> -A6)",
          "natural": "If sterilization is approved, then the batch is not contaminated."
        },
        {
          "step_number": 2,
          "rule_applied": "DE",
          "premises_used": [
            "(A7 | A8)",
            "(A7 -> -A6)",
            "(A8 -> -A6)"
          ],
          "conclusion": "-A6",
          "natural": "The batch is not contaminated."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A6 | (A5 -> G))",
            "-A6"
          ],
          "conclusion": "(A5 -> G)",
          "natural": "Assuming the chemical compound is stable, the medication is safe."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A4 | A5)",
            "(A4 -> G)",
            "(A5 -> G)"
          ],
          "conclusion": "G",
          "natural": "The medication is safe."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "CD",
          "premises_used": [
            "(A15 -> A14)",
            "(A16 -> (-(A11 -> A10) -> -A13))",
            "(A15 | A16)"
          ],
          "conclusion": "(A14 | (-(A11 -> A10) -> -A13))",
          "natural": "Either the manufacturing process is approved, or if it is not the case that positive patient response implies a successful clinical trial, then the trial period is not extended."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A14 | (-(A11 -> A10) -> -A13))",
            "-A14"
          ],
          "conclusion": "(-(A11 -> A10) -> -A13)",
          "natural": "Whenever it is not the case that positive patient response leads to a successful clinical trial, the trial period is not extended."
        },
        {
          "step_number": 3,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(A11 -> A10) -> A13)",
            "(-(A11 -> A10) -> -A13)"
          ],
          "conclusion": "(A11 -> A10)",
          "natural": "Provided that patient response is positive, the clinical trial is successful."
        },
        {
          "step_number": 4,
          "rule_applied": "CD",
          "premises_used": [
            "(A11 -> A10)",
            "(A12 -> G)",
            "(A11 | A12)"
          ],
          "conclusion": "(A10 | G)",
          "natural": "Either the clinical trial is successful or the medication is safe."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A10 | G)",
            "-A10"
          ],
          "conclusion": "G",
          "natural": "The medication is safe."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 1,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(-G -> A17) -> A18) -> A19)",
            "(-(-(-G -> A17) -> A18) -> -A19)"
          ],
          "conclusion": "(-(-G -> A17) -> A18)",
          "natural": "In the event that it is not the case that not safe medication implies initiated phase three, phase three is completed."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(-G -> A17) -> A18)",
            "-A18"
          ],
          "conclusion": "(-G -> A17)",
          "natural": "Should the medication not be safe, phase three is initiated."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(-G -> A17)",
            "(A17 -> A1)"
          ],
          "conclusion": "(-G -> A1)",
          "natural": "If the medication is not safe, then the clinical trial is approved."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-G -> A1)",
            "(-G -> -A1)"
          ],
          "conclusion": "G",
          "natural": "The medication is safe."
        }
      ]
    },
    {
      "id": 5,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 1,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(-(A22 -> (A20 | A21)) -> A24)",
            "(A24 -> A23)"
          ],
          "conclusion": "(-(A22 -> (A20 | A21)) -> A23)",
          "natural": "Should it not be the case that conducted microbial testing implies either detected contamination or identified impurity, then quality assurance is failed."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(-(A22 -> (A20 | A21)) -> A23)",
            "-A23"
          ],
          "conclusion": "(A22 -> (A20 | A21))",
          "natural": "Whenever microbial testing is conducted, either contamination is detected or an impurity is identified."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A22 -> (A20 | A21))",
            "A22"
          ],
          "conclusion": "(A20 | A21)",
          "natural": "Either contamination is detected or an impurity is identified."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A20 | A21)",
            "(A20 -> -A6)",
            "(A21 -> -A6)"
          ],
          "conclusion": "-A6",
          "natural": "The batch is not contaminated."
        },
        {
          "step_number": 5,
          "rule_applied": "DS",
          "premises_used": [
            "(A6 | (A5 -> G))",
            "-A6"
          ],
          "conclusion": "(A5 -> G)",
          "natural": "Assuming the chemical compound is stable, the medication is safe."
        },
        {
          "step_number": 6,
          "rule_applied": "DE",
          "premises_used": [
            "(A4 | A5)",
            "(A4 -> G)",
            "(A5 -> G)"
          ],
          "conclusion": "G",
          "natural": "The medication is safe."
        }
      ]
    },
    {
      "id": 6,
      "family_id": 3,
      "path_type": "branch",
      "branch_from": 2,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MT",
          "premises_used": [
            "(A25 -> A26)",
            "-A26"
          ],
          "conclusion": "-A25",
          "natural": "The product line is not profitable."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A25 | (A11 -> A10))",
            "-A25"
          ],
          "conclusion": "(A11 -> A10)",
          "natural": "Provided that patient response is positive, the clinical trial is successful."
        },
        {
          "step_number": 3,
          "rule_applied": "CD",
          "premises_used": [
            "(A11 -> A10)",
            "(A12 -> G)",
            "(A11 | A12)"
          ],
          "conclusion": "(A10 | G)",
          "natural": "Either the clinical trial is successful or the medication is safe."
        },
        {
          "step_number": 4,
          "rule_applied": "DS",
          "premises_used": [
            "(A10 | G)",
            "-A10"
          ],
          "conclusion": "G",
          "natural": "The medication is safe."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Pharmaceutical Manufacturing",
    "atomic_facts": {
      "A1": "approved(clinical_trial)",
      "A2": "halted(production)",
      "A3": "resumed(production)",
      "A4": "effective(drug_formula)",
      "A5": "stable(chemical_compound)",
      "A6": "contaminated(batch)",
      "A7": "passed(quality_test)",
      "A8": "approved(sterilization)",
      "A9": "completed(packaging)",
      "A10": "successful(clinical_trial)",
      "A11": "positive(patient_response)",
      "A12": "minimal(side_effects)",
      "A13": "extended(trial_period)",
      "A14": "approved(manufacturing_process)",
      "A15": "compliant(regulatory_standards)",
      "A16": "validated(equipment)",
      "A17": "initiated(phase_three)",
      "A18": "completed(phase_three)",
      "A19": "submitted(fda_application)",
      "A20": "detected(contamination)",
      "A21": "identified(impurity)",
      "A22": "conducted(microbial_testing)",
      "A23": "failed(quality_assurance)",
      "A24": "initiated(recall_procedure)",
      "A25": "profitable(product_line)",
      "A26": "increased(market_share)",
      "G": "safe(medication)"
    },
    "natural_facts": {
      "A1": "The clinical trial is approved.",
      "A2": "Production is halted.",
      "A3": "Production is resumed.",
      "A4": "The drug formula is effective.",
      "A5": "The chemical compound is stable.",
      "A6": "The batch is contaminated.",
      "A7": "The quality test is passed.",
      "A8": "Sterilization is approved.",
      "A9": "Packaging is completed.",
      "A10": "The clinical trial is successful.",
      "A11": "Patient response is positive.",
      "A12": "Side effects are minimal.",
      "A13": "The trial period is extended.",
      "A14": "The manufacturing process is approved.",
      "A15": "Regulatory standards are compliant.",
      "A16": "Equipment is validated.",
      "A17": "Phase three is initiated.",
      "A18": "Phase three is completed.",
      "A19": "The FDA application is submitted.",
      "A20": "Contamination is detected.",
      "A21": "An impurity is identified.",
      "A22": "Microbial testing is conducted.",
      "A23": "Quality assurance is failed.",
      "A24": "Recall procedure is initiated.",
      "A25": "The product line is profitable.",
      "A26": "Market share is increased.",
      "G": "The medication is safe."
    },
    "prover9_expressions": [
      "(successful(clinical_trial) | safe(medication))",
      "(positive(patient_response) -> successful(clinical_trial))",
      "(positive(patient_response) | minimal(side_effects))",
      "(minimal(side_effects) -> safe(medication))",
      "(approved(manufacturing_process) | (-(positive(patient_response) -> successful(clinical_trial)) -> -extended(trial_period)))",
      "(compliant(regulatory_standards) -> approved(manufacturing_process))",
      "(compliant(regulatory_standards) | validated(equipment))",
      "(validated(equipment) -> (-(positive(patient_response) -> successful(clinical_trial)) -> -extended(trial_period)))",
      "(initiated(phase_three) -> approved(clinical_trial))",
      "(detected(contamination) -> -contaminated(batch))",
      "(detected(contamination) | identified(impurity))",
      "(identified(impurity) -> -contaminated(batch))",
      "(conducted(microbial_testing) -> (detected(contamination) | identified(impurity)))",
      "(initiated(recall_procedure) -> failed(quality_assurance))",
      "(profitable(product_line) -> increased(market_share))",
      "(profitable(product_line) | (positive(patient_response) -> successful(clinical_trial)))",
      "(resumed(production) -> -halted(production))",
      "(effective(drug_formula) -> safe(medication))",
      "(effective(drug_formula) | stable(chemical_compound))",
      "(stable(chemical_compound) -> safe(medication))",
      "(contaminated(batch) | (stable(chemical_compound) -> safe(medication)))",
      "(passed(quality_test) -> -contaminated(batch))",
      "(passed(quality_test) | approved(sterilization))",
      "(approved(sterilization) -> completed(packaging))",
      "(approved(sterilization) -> -contaminated(batch))",
      "(completed(packaging) -> -contaminated(batch))",
      "(-(positive(patient_response) -> successful(clinical_trial)) -> extended(trial_period))",
      "(-(positive(patient_response) -> successful(clinical_trial)) -> -extended(trial_period))",
      "(-(conducted(microbial_testing) -> (detected(contamination) | identified(impurity))) -> failed(quality_assurance))",
      "(-(conducted(microbial_testing) -> (detected(contamination) | identified(impurity))) -> initiated(recall_procedure))",
      "(-(-(-safe(medication) -> initiated(phase_three)) -> completed(phase_three)) -> submitted(fda_application))",
      "(-(-(-safe(medication) -> initiated(phase_three)) -> completed(phase_three)) -> -submitted(fda_application))",
      "(-(-safe(medication) -> approved(clinical_trial)) -> halted(production))",
      "(-(-safe(medication) -> approved(clinical_trial)) -> resumed(production))",
      "(-(-safe(medication) -> approved(clinical_trial)) -> -halted(production))",
      "(-(-safe(medication) -> initiated(phase_three)) -> completed(phase_three))",
      "(-safe(medication) -> approved(clinical_trial))",
      "(-safe(medication) -> initiated(phase_three))",
      "(-safe(medication) -> -approved(clinical_trial))",
      "conducted(microbial_testing)",
      "safe(medication)",
      "-successful(clinical_trial)",
      "-approved(manufacturing_process)",
      "-completed(phase_three)",
      "-failed(quality_assurance)",
      "-profitable(product_line)",
      "-increased(market_share)",
      "-contaminated(batch)"
    ],
    "natural_expressions": [
      "Either the clinical trial is successful or the medication is safe.",
      "Provided that patient response is positive, the clinical trial is successful.",
      "Patient response is positive or side effects are minimal.",
      "Whenever side effects are minimal, the medication is safe.",
      "Either the manufacturing process is approved, or if it is not the case that positive patient response implies a successful clinical trial, then the trial period is not extended.",
      "If regulatory standards are compliant, then the manufacturing process is approved.",
      "Regulatory standards are compliant or equipment is validated.",
      "Assuming equipment is validated, then if it is not the case that positive patient response leads to a successful clinical trial, the trial period is not extended.",
      "In the event that phase three is initiated, the clinical trial is approved.",
      "Given that contamination is detected, the batch is not contaminated.",
      "Either contamination is detected or an impurity is identified.",
      "Should an impurity be identified, the batch is not contaminated.",
      "Whenever microbial testing is conducted, either contamination is detected or an impurity is identified.",
      "If recall procedure is initiated, then quality assurance is failed.",
      "Provided that the product line is profitable, market share is increased.",
      "The product line is profitable or positive patient response implies a successful clinical trial.",
      "In the case that production is resumed, production is not halted.",
      "If the drug formula is effective, then the medication is safe.",
      "Either the drug formula is effective or the chemical compound is stable.",
      "Assuming the chemical compound is stable, the medication is safe.",
      "The batch is contaminated or if the chemical compound is stable, then the medication is safe.",
      "Should the quality test be passed, the batch is not contaminated.",
      "Either the quality test is passed or sterilization is approved.",
      "Provided that sterilization is approved, packaging is completed.",
      "If sterilization is approved, then the batch is not contaminated.",
      "In the event that packaging is completed, the batch is not contaminated.",
      "If it is not the case that positive patient response implies a successful clinical trial, then the trial period is extended.",
      "Whenever it is not the case that positive patient response leads to a successful clinical trial, the trial period is not extended.",
      "Should it not be the case that conducted microbial testing implies either detected contamination or identified impurity, then quality assurance is failed.",
      "If it is not the case that conducted microbial testing leads to either detected contamination or identified impurity, then recall procedure is initiated.",
      "Provided that it is not the case that not not safe medication implies initiated phase three leads to completed phase three, then the FDA application is submitted.",
      "In the case that it is not the case that not not safe medication implies initiated phase three leads to completed phase three, then the FDA application is not submitted.",
      "If it is not the case that not safe medication implies approved clinical trial, then production is halted.",
      "Assuming it is not the case that not safe medication implies approved clinical trial, production is resumed.",
      "Provided that it is not the case that not safe medication implies approved clinical trial, production is not halted.",
      "In the event that it is not the case that not safe medication implies initiated phase three, phase three is completed.",
      "If the medication is not safe, then the clinical trial is approved.",
      "Should the medication not be safe, phase three is initiated.",
      "Whenever the medication is not safe, the clinical trial is not approved.",
      "Microbial testing is conducted.",
      "The medication is safe.",
      "It is not the case that the clinical trial is successful.",
      "The manufacturing process is not approved.",
      "Phase three is not completed.",
      "Quality assurance is not failed.",
      "The product line is not profitable.",
      "Market share is not increased.",
      "The batch is not contaminated."
    ],
    "node_mappings": {
      "(A10 ∨ G)": {
        "formal": "(A10 ∨ G)",
        "prover9": "(A10 | G)",
        "prover9_expression": "(successful(clinical_trial) | safe(medication))",
        "natural": "Either the clinical trial is successful or the medication is safe."
      },
      "(A11 → A10)": {
        "formal": "(A11 → A10)",
        "prover9": "(A11 -> A10)",
        "prover9_expression": "(positive(patient_response) -> successful(clinical_trial))",
        "natural": "Provided that patient response is positive, the clinical trial is successful."
      },
      "(A11 ∨ A12)": {
        "formal": "(A11 ∨ A12)",
        "prover9": "(A11 | A12)",
        "prover9_expression": "(positive(patient_response) | minimal(side_effects))",
        "natural": "Patient response is positive or side effects are minimal."
      },
      "(A12 → G)": {
        "formal": "(A12 → G)",
        "prover9": "(A12 -> G)",
        "prover9_expression": "(minimal(side_effects) -> safe(medication))",
        "natural": "Whenever side effects are minimal, the medication is safe."
      },
      "(A14 ∨ (¬(A11 → A10) → ¬A13))": {
        "formal": "(A14 ∨ (¬(A11 → A10) → ¬A13))",
        "prover9": "(A14 | (-(A11 -> A10) -> -A13))",
        "prover9_expression": "(approved(manufacturing_process) | (-(positive(patient_response) -> successful(clinical_trial)) -> -extended(trial_period)))",
        "natural": "Either the manufacturing process is approved, or if it is not the case that positive patient response implies a successful clinical trial, then the trial period is not extended."
      },
      "(A15 → A14)": {
        "formal": "(A15 → A14)",
        "prover9": "(A15 -> A14)",
        "prover9_expression": "(compliant(regulatory_standards) -> approved(manufacturing_process))",
        "natural": "If regulatory standards are compliant, then the manufacturing process is approved."
      },
      "(A15 ∨ A16)": {
        "formal": "(A15 ∨ A16)",
        "prover9": "(A15 | A16)",
        "prover9_expression": "(compliant(regulatory_standards) | validated(equipment))",
        "natural": "Regulatory standards are compliant or equipment is validated."
      },
      "(A16 → (¬(A11 → A10) → ¬A13))": {
        "formal": "(A16 → (¬(A11 → A10) → ¬A13))",
        "prover9": "(A16 -> (-(A11 -> A10) -> -A13))",
        "prover9_expression": "(validated(equipment) -> (-(positive(patient_response) -> successful(clinical_trial)) -> -extended(trial_period)))",
        "natural": "Assuming equipment is validated, then if it is not the case that positive patient response leads to a successful clinical trial, the trial period is not extended."
      },
      "(A17 → A1)": {
        "formal": "(A17 → A1)",
        "prover9": "(A17 -> A1)",
        "prover9_expression": "(initiated(phase_three) -> approved(clinical_trial))",
        "natural": "In the event that phase three is initiated, the clinical trial is approved."
      },
      "(A20 → ¬A6)": {
        "formal": "(A20 → ¬A6)",
        "prover9": "(A20 -> -A6)",
        "prover9_expression": "(detected(contamination) -> -contaminated(batch))",
        "natural": "Given that contamination is detected, the batch is not contaminated."
      },
      "(A20 ∨ A21)": {
        "formal": "(A20 ∨ A21)",
        "prover9": "(A20 | A21)",
        "prover9_expression": "(detected(contamination) | identified(impurity))",
        "natural": "Either contamination is detected or an impurity is identified."
      },
      "(A21 → ¬A6)": {
        "formal": "(A21 → ¬A6)",
        "prover9": "(A21 -> -A6)",
        "prover9_expression": "(identified(impurity) -> -contaminated(batch))",
        "natural": "Should an impurity be identified, the batch is not contaminated."
      },
      "(A22 → (A20 ∨ A21))": {
        "formal": "(A22 → (A20 ∨ A21))",
        "prover9": "(A22 -> (A20 | A21))",
        "prover9_expression": "(conducted(microbial_testing) -> (detected(contamination) | identified(impurity)))",
        "natural": "Whenever microbial testing is conducted, either contamination is detected or an impurity is identified."
      },
      "(A24 → A23)": {
        "formal": "(A24 → A23)",
        "prover9": "(A24 -> A23)",
        "prover9_expression": "(initiated(recall_procedure) -> failed(quality_assurance))",
        "natural": "If recall procedure is initiated, then quality assurance is failed."
      },
      "(A25 → A26)": {
        "formal": "(A25 → A26)",
        "prover9": "(A25 -> A26)",
        "prover9_expression": "(profitable(product_line) -> increased(market_share))",
        "natural": "Provided that the product line is profitable, market share is increased."
      },
      "(A25 ∨ (A11 → A10))": {
        "formal": "(A25 ∨ (A11 → A10))",
        "prover9": "(A25 | (A11 -> A10))",
        "prover9_expression": "(profitable(product_line) | (positive(patient_response) -> successful(clinical_trial)))",
        "natural": "The product line is profitable or positive patient response implies a successful clinical trial."
      },
      "(A3 → ¬A2)": {
        "formal": "(A3 → ¬A2)",
        "prover9": "(A3 -> -A2)",
        "prover9_expression": "(resumed(production) -> -halted(production))",
        "natural": "In the case that production is resumed, production is not halted."
      },
      "(A4 → G)": {
        "formal": "(A4 → G)",
        "prover9": "(A4 -> G)",
        "prover9_expression": "(effective(drug_formula) -> safe(medication))",
        "natural": "If the drug formula is effective, then the medication is safe."
      },
      "(A4 ∨ A5)": {
        "formal": "(A4 ∨ A5)",
        "prover9": "(A4 | A5)",
        "prover9_expression": "(effective(drug_formula) | stable(chemical_compound))",
        "natural": "Either the drug formula is effective or the chemical compound is stable."
      },
      "(A5 → G)": {
        "formal": "(A5 → G)",
        "prover9": "(A5 -> G)",
        "prover9_expression": "(stable(chemical_compound) -> safe(medication))",
        "natural": "Assuming the chemical compound is stable, the medication is safe."
      },
      "(A6 ∨ (A5 → G))": {
        "formal": "(A6 ∨ (A5 → G))",
        "prover9": "(A6 | (A5 -> G))",
        "prover9_expression": "(contaminated(batch) | (stable(chemical_compound) -> safe(medication)))",
        "natural": "The batch is contaminated or if the chemical compound is stable, then the medication is safe."
      },
      "(A7 → ¬A6)": {
        "formal": "(A7 → ¬A6)",
        "prover9": "(A7 -> -A6)",
        "prover9_expression": "(passed(quality_test) -> -contaminated(batch))",
        "natural": "Should the quality test be passed, the batch is not contaminated."
      },
      "(A7 ∨ A8)": {
        "formal": "(A7 ∨ A8)",
        "prover9": "(A7 | A8)",
        "prover9_expression": "(passed(quality_test) | approved(sterilization))",
        "natural": "Either the quality test is passed or sterilization is approved."
      },
      "(A8 → A9)": {
        "formal": "(A8 → A9)",
        "prover9": "(A8 -> A9)",
        "prover9_expression": "(approved(sterilization) -> completed(packaging))",
        "natural": "Provided that sterilization is approved, packaging is completed."
      },
      "(A8 → ¬A6)": {
        "formal": "(A8 → ¬A6)",
        "prover9": "(A8 -> -A6)",
        "prover9_expression": "(approved(sterilization) -> -contaminated(batch))",
        "natural": "If sterilization is approved, then the batch is not contaminated."
      },
      "(A9 → ¬A6)": {
        "formal": "(A9 → ¬A6)",
        "prover9": "(A9 -> -A6)",
        "prover9_expression": "(completed(packaging) -> -contaminated(batch))",
        "natural": "In the event that packaging is completed, the batch is not contaminated."
      },
      "(¬(A11 → A10) → A13)": {
        "formal": "(¬(A11 → A10) → A13)",
        "prover9": "(-(A11 -> A10) -> A13)",
        "prover9_expression": "(-(positive(patient_response) -> successful(clinical_trial)) -> extended(trial_period))",
        "natural": "If it is not the case that positive patient response implies a successful clinical trial, then the trial period is extended."
      },
      "(¬(A11 → A10) → ¬A13)": {
        "formal": "(¬(A11 → A10) → ¬A13)",
        "prover9": "(-(A11 -> A10) -> -A13)",
        "prover9_expression": "(-(positive(patient_response) -> successful(clinical_trial)) -> -extended(trial_period))",
        "natural": "Whenever it is not the case that positive patient response leads to a successful clinical trial, the trial period is not extended."
      },
      "(¬(A22 → (A20 ∨ A21)) → A23)": {
        "formal": "(¬(A22 → (A20 ∨ A21)) → A23)",
        "prover9": "(-(A22 -> (A20 | A21)) -> A23)",
        "prover9_expression": "(-(conducted(microbial_testing) -> (detected(contamination) | identified(impurity))) -> failed(quality_assurance))",
        "natural": "Should it not be the case that conducted microbial testing implies either detected contamination or identified impurity, then quality assurance is failed."
      },
      "(¬(A22 → (A20 ∨ A21)) → A24)": {
        "formal": "(¬(A22 → (A20 ∨ A21)) → A24)",
        "prover9": "(-(A22 -> (A20 | A21)) -> A24)",
        "prover9_expression": "(-(conducted(microbial_testing) -> (detected(contamination) | identified(impurity))) -> initiated(recall_procedure))",
        "natural": "If it is not the case that conducted microbial testing leads to either detected contamination or identified impurity, then recall procedure is initiated."
      },
      "(¬(¬(¬G → A17) → A18) → A19)": {
        "formal": "(¬(¬(¬G → A17) → A18) → A19)",
        "prover9": "(-(-(-G -> A17) -> A18) -> A19)",
        "prover9_expression": "(-(-(-safe(medication) -> initiated(phase_three)) -> completed(phase_three)) -> submitted(fda_application))",
        "natural": "Provided that it is not the case that not not safe medication implies initiated phase three leads to completed phase three, then the FDA application is submitted."
      },
      "(¬(¬(¬G → A17) → A18) → ¬A19)": {
        "formal": "(¬(¬(¬G → A17) → A18) → ¬A19)",
        "prover9": "(-(-(-G -> A17) -> A18) -> -A19)",
        "prover9_expression": "(-(-(-safe(medication) -> initiated(phase_three)) -> completed(phase_three)) -> -submitted(fda_application))",
        "natural": "In the case that it is not the case that not not safe medication implies initiated phase three leads to completed phase three, then the FDA application is not submitted."
      },
      "(¬(¬G → A1) → A2)": {
        "formal": "(¬(¬G → A1) → A2)",
        "prover9": "(-(-G -> A1) -> A2)",
        "prover9_expression": "(-(-safe(medication) -> approved(clinical_trial)) -> halted(production))",
        "natural": "If it is not the case that not safe medication implies approved clinical trial, then production is halted."
      },
      "(¬(¬G → A1) → A3)": {
        "formal": "(¬(¬G → A1) → A3)",
        "prover9": "(-(-G -> A1) -> A3)",
        "prover9_expression": "(-(-safe(medication) -> approved(clinical_trial)) -> resumed(production))",
        "natural": "Assuming it is not the case that not safe medication implies approved clinical trial, production is resumed."
      },
      "(¬(¬G → A1) → ¬A2)": {
        "formal": "(¬(¬G → A1) → ¬A2)",
        "prover9": "(-(-G -> A1) -> -A2)",
        "prover9_expression": "(-(-safe(medication) -> approved(clinical_trial)) -> -halted(production))",
        "natural": "Provided that it is not the case that not safe medication implies approved clinical trial, production is not halted."
      },
      "(¬(¬G → A17) → A18)": {
        "formal": "(¬(¬G → A17) → A18)",
        "prover9": "(-(-G -> A17) -> A18)",
        "prover9_expression": "(-(-safe(medication) -> initiated(phase_three)) -> completed(phase_three))",
        "natural": "In the event that it is not the case that not safe medication implies initiated phase three, phase three is completed."
      },
      "(¬G → A1)": {
        "formal": "(¬G → A1)",
        "prover9": "(-G -> A1)",
        "prover9_expression": "(-safe(medication) -> approved(clinical_trial))",
        "natural": "If the medication is not safe, then the clinical trial is approved."
      },
      "(¬G → A17)": {
        "formal": "(¬G → A17)",
        "prover9": "(-G -> A17)",
        "prover9_expression": "(-safe(medication) -> initiated(phase_three))",
        "natural": "Should the medication not be safe, phase three is initiated."
      },
      "(¬G → ¬A1)": {
        "formal": "(¬G → ¬A1)",
        "prover9": "(-G -> -A1)",
        "prover9_expression": "(-safe(medication) -> -approved(clinical_trial))",
        "natural": "Whenever the medication is not safe, the clinical trial is not approved."
      },
      "A22": {
        "formal": "A22",
        "prover9": "A22",
        "prover9_expression": "conducted(microbial_testing)",
        "natural": "Microbial testing is conducted."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "safe(medication)",
        "natural": "The medication is safe."
      },
      "¬A10": {
        "formal": "¬A10",
        "prover9": "-A10",
        "prover9_expression": "-successful(clinical_trial)",
        "natural": "It is not the case that the clinical trial is successful."
      },
      "¬A14": {
        "formal": "¬A14",
        "prover9": "-A14",
        "prover9_expression": "-approved(manufacturing_process)",
        "natural": "The manufacturing process is not approved."
      },
      "¬A18": {
        "formal": "¬A18",
        "prover9": "-A18",
        "prover9_expression": "-completed(phase_three)",
        "natural": "Phase three is not completed."
      },
      "¬A23": {
        "formal": "¬A23",
        "prover9": "-A23",
        "prover9_expression": "-failed(quality_assurance)",
        "natural": "Quality assurance is not failed."
      },
      "¬A25": {
        "formal": "¬A25",
        "prover9": "-A25",
        "prover9_expression": "-profitable(product_line)",
        "natural": "The product line is not profitable."
      },
      "¬A26": {
        "formal": "¬A26",
        "prover9": "-A26",
        "prover9_expression": "-increased(market_share)",
        "natural": "Market share is not increased."
      },
      "¬A6": {
        "formal": "¬A6",
        "prover9": "-A6",
        "prover9_expression": "-contaminated(batch)",
        "natural": "The batch is not contaminated."
      }
    }
  }
}